Table 2: Baseline characteristics and MRI findings ().

Patient characteristics

Age (years)a42.5 (38.8–47.8)
BMI (kg/m2)a23.1 (19.9–28.1)
Symptomsb
 Menorrhagia3 (38%)
 Bulky symptoms4 (50%)
 Infertility1 (12%)
tSSSa57.9 (38.3–79.0)
Total HRQoLa48.7 (28.9–80.4)

Lesion characteristics

Number of fibroidsb
 Solitary fibroid2 (25%)
 Multiple fibroids6 (75%)
  2–5 fibroids4 (67%)
  6–10 fibroids2 (33%)
Location of fibroidsb
 Intramural6 (67%)
 Submucosal3 (33%)
Type of fibroidb
 Type 14 (45%)
 Type 23 (33%)
 Type 32 (22%)
Maximum fibroid diameter (cm)a7.7 (5.1–8.8)
Uterine fibroid volume (cm3)a147 (49–338)

Median (interquartile range); bnumber (percentage); MR-HIFU: MR-guided high-intensity focused ultrasound; tSSS: transformed symptom severity score (range 0–100); high scores indicate more severe symptoms; HRQoL: health-related quality of life (range 0–100); high scores indicate better quality of life; type 1: low signal intensity on T2-weighted imaging; type 2: intermediate signal intensity on T2-weighted imaging; type 3: high signal intensity on T2-weighted imaging; NPV: nonperfused volume.